Newborn antibodies following maternal COVID-19 vaccination persist for up to
March 19, 2022
In most developed countries, several vaccines have been developed against the coronavirus disease 2019 (COVID-19), all of which target the immunodominant spike antigen of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A new JAMA study discusses the antibody levels in the newborns born from mothers who have been vaccinated against …
